BioCryst: 3Q Earnings Snapshot

November 6, 2018

DURHAM, N.C. (AP) _ BioCryst Pharmaceuticals Inc. (BCRX) on Tuesday reported a loss of $29.6 million in its third quarter.

On a per-share basis, the Durham, North Carolina-based company said it had a loss of 28 cents.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.

The drugmaker posted revenue of $1.5 million in the period, which also missed Street forecasts. Three analysts surveyed by Zacks expected $2.5 million.

BioCryst shares have increased 62 percent since the beginning of the year. The stock has climbed 69 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BCRX at https://www.zacks.com/ap/BCRX

Update hourly